The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
Open accessAbstract
Ebola virus (EboV) is a highly pathogenic enveloped virus that causes outbreaks of zoonotic infection in Africa. The clinical symptoms are manifestations of the massive production of pro-inflammatory cytokines in response to infection and in many outbreaks, mortality exceeds 75%. The unpredictable onset, ease of transmission, rapid progression of disease, high mortality and lack of effective vaccine or therapy have created a high level of public concern about EboV. Here we report the identification of a novel benzylpiperazine adamantane diamide-derived compound that inhibits EboV infection. Using mutant cell lines and informative derivatives of the lead compound, we show that the target of the inhibitor is the endosomal membrane protein Niemann–Pick C1 (NPC1). We find that NPC1 is essential for infection, that it binds to the virus glycoprotein (GP), and that antiviral compounds interfere with GP binding to NPC1. Combined with the results of previous studies of GP structure and function, our findings support a model of EboV infection in which cleavage of the GP1 subunit by endosomal cathepsin proteases removes heavily glycosylated domains to expose the amino-terminal domain, which is a ligand for NPC1 and regulates membrane fusion by the GP2 subunit. Thus, NPC1 is essential for EboV entry and a target for antiviral therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison, S. C. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1456 · Cited by 1,190
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. (2005) · Science · doi:10.1126/science.1110656 · Cited by 826
Self-citationStructure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., & Saphire, E. O. (2008) · Nature · doi:10.1038/nature07082 · Cited by 736
A transient three-plasmid expression system for the production of high titer retroviral vectors
Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., & Kingsman, A. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.4.628 · Cited by 690
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Towner, J. S., Sealy, T. K., Khristova, M. L., Albariño, C. G., Conlan, S., Reeder, S. A., Quan, P.-L., Lipkin, W. I., Downing, R., Tappero, J. W., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000212 · Cited by 599
Exotic emerging viral diseases: progress and challenges
Geisbert, T. W., & Jahrling, P. B. (2004) · Nature Medicine · doi:10.1038/nm1142 · Cited by 441
Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., & Kawaoka, Y. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001121 · Cited by 437
Saeed, M. F., Kolokoltsov, A. A., Albrecht, T., & Davey, R. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001110 · Cited by 427
Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein
Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., & White, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.4174-4178.2006 · Cited by 414
A role for oxysterol-binding protein–related protein 5 in endosomal cholesterol trafficking
Du, X., Kumar, J., Ferguson, C., Schulz, T. A., Ong, Y. S., Hong, W., Prinz, W. A., Parton, R. G., Brown, A. J., & Yang, H. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201004142 · Cited by 313
Cited by
Harrison, S. C. (2015) · Virology · doi:10.1016/j.virol.2015.03.043 · Cited by 697
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
Sakurai, Y., Kolokoltsov, A. A., Chen, C.-C., Tidwell, M. W., Bauta, W. E., Klugbauer, N., Grimm, C., Wahl-Schott, C., Biel, M., & Davey, R. A. (2015) · Science · doi:10.1126/science.1258758 · Cited by 555
Bat-borne virus diversity, spillover and emergence
Letko, M., Seifert, S. N., Olival, K. J., Plowright, R. K., & Munster, V. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0394-z · Cited by 553
The cell biology of receptor-mediated virus entry
Grove, J., & Marsh, M. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108131 · Cited by 510
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Corti, D., Misasi, J., Mulangu, S., Stanley, D. A., Kanekiyo, M., Wollen, S., Ploquin, A., Doria-Rose, N. A., Staupe, R. P., Bailey, M., et al. (2016) · Science · doi:10.1126/science.aad5224 · Cited by 408
Self-citationMulti-organ proteomic landscape of COVID-19 autopsies
Nie, X., Qian, L., Sun, R., Huang, B., Dong, X., Xiao, Q., Zhang, Q., Lu, T., Yue, L., Chen, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.004 · Cited by 408
Fusion of Enveloped Viruses in Endosomes
White, J. M., & Whittaker, G. R. (2016) · Traffic · doi:10.1111/tra.12389 · Cited by 397
The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses
Goldstein, T., Anthony, S. J., Gbakima, A., Bird, B. H., Bangura, J., Tremeau-Bravard, A., Belaganahalli, M. N., Wells, H. L., Dhanota, J. K., Liang, E., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0227-2 · Cited by 385
Self-citationRecent advances in siRNA delivery mediated by lipid-based nanoparticles
Yonezawa, S., Koide, H., & Asai, T. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.022 · Cited by 378
Jemielity, S., Wang, J. J., Chan, Y. K., Ahmed, A. A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G. J., Umetsu, D. T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003232 · Cited by 364
The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry
Amini-Bavil-Olyaee, S., Choi, Y. J., Lee, J. H., Shi, M., Huang, I.-C., Farzan, M., & Jung, J. U. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.006 · Cited by 348
Ebola virus entry requires the host‐programmed recognition of an intracellular receptor
Miller, E. H., Obernosterer, G., Raaben, M., Herbert, A. S., Deffieu, M. S., Krishnan, A., Ndungo, E., Sandesara, R. G., Carette, J. E., Kuehne, A. I., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.53 · Cited by 335
Self-citationALIX and the multivesicular endosome: ALIX in Wonderland
Bissig, C., & Gruenberg, J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.10.009 · Cited by 323
Lu, F., Liang, Q., Abi-Mosleh, L., Das, A., De Brabander, J. K., Goldstein, J. L., & Brown, M. S. (2015) · eLife · doi:10.7554/elife.12177 · Cited by 333
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Johansen, L. M., Brannan, J. M., Delos, S. E., Shoemaker, C. J., Stossel, A., Lear, C., Hoffstrom, B. G., DeWald, L. E., Schornberg, K. L., Scully, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005471 · Cited by 332
Self-citationDesai, T. M., Marin, M., Chin, C. R., Savidis, G., Brass, A. L., & Melikyan, G. B. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004048 · Cited by 326
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E., & Zaki, S. R. (2015) · The Journal of Pathology · doi:10.1002/path.4456 · Cited by 319
The evolution of Ebola virus: Insights from the 2013-2016 epidemic
Holmes, E. C., Dudas, G., Rambaut, A., & Andersen, K. G. (2016) · Nature · doi:10.1038/nature19790 · Cited by 314
Gong, X., Qian, H., Zhou, X., Wu, J., Wan, T., Cao, P., Huang, W., Zhao, X., Wang, X., Wang, P., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.022 · Cited by 312
Evolutionary insights into host–pathogen interactions from mammalian sequence data
Sironi, M., Cagliani, R., Forni, D., & Clerici, M. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3905 · Cited by 302
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
Wang, H., Shi, Y., Song, J., Qi, J., Lu, G., Yan, J., & Gao, G. F. (2016) · Cell · doi:10.1016/j.cell.2015.12.044 · Cited by 289
Zhou, N., Pan, T., Zhang, J., Li, Q., Zhang, X., Bai, C., Huang, F., Peng, T., Zhang, J., Liu, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716100 · Cited by 286
Self-citationRole of the Phosphatidylserine Receptor TIM-1 in Enveloped-Virus Entry
Moller-Tank, S., Kondratowicz, A. S., Davey, R. A., Rennert, P. D., & Maury, W. (2013) · Journal of Virology · doi:10.1128/jvi.01025-13 · Cited by 285
Antibodies to combat viral infections: development strategies and progress
Pantaleo, G., Correia, B., Fenwick, C., Joo, V. S., & Perez, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 279
Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses
Yin, X., Ambardekar, C., Lu, Y., & Feng, Z. (2016) · Journal of Virology · doi:10.1128/jvi.02804-15 · Cited by 275
Forty-Five Years of Marburg Virus Research
Brauburger, K., Hume, A. J., Mühlberger, E., & Olejnik, J. (2012) · Viruses · doi:10.3390/v4101878 · Cited by 268
Lysosomal Membrane Proteins and Their Central Role in Physiology
Schwake, M., Schröder, B., & Saftig, P. (2013) · Traffic · doi:10.1111/tra.12056 · Cited by 258
Structural Basis of Low-pH-Dependent Lysosomal Cholesterol Egress by NPC1 and NPC2
Qian, H., Wu, X., Du, X., Yao, X., Zhao, X., Lee, J., Yang, H., & Yan, N. (2020) · Cell · doi:10.1016/j.cell.2020.05.020 · Cited by 185
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Lysosomal enzyme trafficking: from molecular mechanisms to human diseases
Braulke, T., Carette, J. E., & Palm, W. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.06.005 · Cited by 76
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors
Capuzzi, S. J., Sun, W., Muratov, E. N., Martínez-Romero, C., He, S., Zhu, W., Li, H., Tawa, G., Fisher, E. G., Xu, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00035 · Cited by 35
Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents
Chang, J., Guo, J.-T., Du, Y., & Block, T. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.77 · Cited by 22
Metadata
- Authors
- Côté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., & Cunningham, J.
- Venue
- Nature
- Published
- 2011-08-24
- Volume
- 477
- Issue
- 7364
- Pages
- 344-348
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2043829974
- Cited by
- 686
- References
- 30
- FWCI
- 27.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.